Sharda Cropchem enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
6,156————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
581581422246208
0.50.50.40.40.4
0.00.00.03.43.0
5,575————
−581−581−422−243−205
₹617.93————
3,1373,1372,5012,2412,235
0.0%0.0%0.0%0.2%0.1%
1.04×————
5.33×————
7.96×————
35.20×————
Reference items — trailing FY values
5,3575,2684,3203,1634,045
1,0471,076596283643
70075232115.7395
—656604341328
15815821169.284.2
—15821068.083.9
—497393272244
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SHARDACROP₹682.30

Sharda Cropchem Ltd.

· Chemicals
₹ CrorePeersUPLPIINDSTYRENIXREFEXSUDARSCHEMSUDEEPPHRMRCFRALLISMcap ₹6,156 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————6,155.7
- Cash, Equiv & ST Investments208.3246.2421.5581.3581.3
+ Minority Interest0.40.40.40.50.5
+ Total Debt3.03.40.00.00.0
Enterprise Value————5,575.0
Net Debt (memo)-205.3-242.9-421.5-581.3-581.3
EV per Share————617.93
Total Capital2,235.32,240.92,501.03,137.03,137.0
Total Debt/Total Capital0.130.150.000.000.00
EV/Sales————1.04
EV/EBITDA————5.33
EV/EBIT————7.96
EV/Free Cash Flow————35.20
Reference Items — Trailing FY Values
Sales4,045.23,163.04,319.95,267.65,356.5
EBITDA643.1282.9595.61,076.21,046.9
EBIT395.015.7320.9751.7700.2
Operating Cash Flow328.3341.3603.6655.7—
Free Cash Flow84.269.2210.6158.4158.4
FCFF (free cash flow to the firm)83.968.0210.3158.1—
Capital Expenditure244.1272.1393.1497.3—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.